Mnemo Therapeutics is a biotechnology company focused on developing powerful cell therapies that create accessible cures for solid tumors and blood cancers. Its EnfiniT platform, a groundbreaking drug discovery engine, leverages a new class of antigens with greater tumor specificity and a suite of technologies to significantly improve T cell memory, persistence, and sensitivity. The result is dramatic improvement in the body’s immune response to overcome disease. Mnemo is built by a transatlantic team of scientists and biotech leaders united in their mission to create the most powerful immune therapies to deliver accessible cures for all patients in need.

Biotechnology

Mnemo Therapeutics

Mariana Gajardo

Christine Foster

Bénédicte Balland

Nadia Kaci-Chaouche

Bertrand Vannier

Nil Ege

Justin Eyquem

Michael Saitakis

The Leadership Team at Mnemo Therapeutics is responsible for guiding the company's strategic vision and advancing its innovative research initiatives. Composed of esteemed scientific co-founders, the team collaborates to oversee the development of the EnfiniT platform and ensure that cutting-edge cell therapies are effectively brought to market. Their collective expertise drives the mission to deliver transformative cures for solid tumors and blood cancers, fostering a culture of collaboration and scientific excellence.

Leadership Team

Scientific Team

Scientific and Laboratory Operations

Leadership Team

About

Team members

Other teams at Mnemo Therapeutics

Scientific Team

Scientific and Laboratory Operations